PSP is an age‐associated tauopathy that clinically manifests as parkinsonism with additional motor abnormalities and cognitive dysfunction (Orr et al., 2017) and is neuropathologically defined by the accumulation of four‐repeat (4R) tau, NFTs, gliosis, and neurodegeneration (Flament, Delacourte, Verny, Hauw, & Javoy‐Agid, 1991). Here, MAPT is linked to supranuclear palsy, progressive, 1.